KainosHQ United Kingdom · Europe
Infrastructure & cloud
FY2026 revenue £431.1m (+17.4%); operating margin 12.7%; net income £42.5m.
No debt; £89.1m cash.
Financial health: StrongRisk summary →
No reviews yet
View profileSuppliers starting with “K”
Showing 1–7 of 7
Kheiron Medical TechnologiesHQ United Kingdom · Europe
Clinical AI & decision supportImaging, PACS & RIS
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Financial health: Not assessedRisk summary →
No reviews yet
View profileKomodo HealthHQ United States · North America
Clinical trials & life sciencesPopulation health & analytics
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Financial health: Not assessedRisk summary →
No reviews yet
View profileKonica MinoltaHQ Japan · Asia-Pacific
Imaging, PACS & RIS
FY2025 revenue ¥1.09tn (-3.6%); operating margin 4.6%; net income ¥30.3bn.
Continuing operations; returned to operating profit from a ¥64.0bn loss.
Financial health: FairRisk summary →
No reviews yet
View profileKoothHQ United Kingdom · Europe
Digital therapeutics & appsMental health, community & social care
FY2025 revenue £63.3m (-5.1%).
Adjusted EBITDA £11.3m (from £15.8m); £21.6m cash, no debt.
Financial health: Not assessedRisk summary →
No reviews yet
View profileKryHQ Sweden · Europe
Telehealth & virtual care
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Financial health: Not assessedRisk summary →
No reviews yet
View profileKyruus HealthHQ United States · North America
Patient engagement & access
Not stock-market listed and no listed parent identified, so no public annual accounts were found.
Financial health not assessed; a credit-agency licence (e.g. Dun & Bradstreet) would be needed.
Financial health: Not assessedRisk summary →
No reviews yet
View profile